• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉西他滨和顺铂化疗栓塞治疗后分化不良转移性胰腺癌 1 年生存。

One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.

机构信息

Division of Interventional Radiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Oncol Rep. 2010 Sep;24(3):767-9. doi: 10.3892/or_00000919.

DOI:10.3892/or_00000919
PMID:20664985
Abstract

While hepatic arterial chemoembolization is efficacious for a number of malignancies, there is scant data regarding treatment of pancreatic adenocarcinoma. We report a complete radiographic response at one year from diagnosis of metastatic pancreatic carcinoma. Gemcitabine/cisplatin based chemoembolization may be of potential benefit for patients with liver-dominant metastases from pancreatic carcinoma. Given the typical survival of 6 months or less in this patient group with standard therapies, further research is warranted.

摘要

肝动脉化疗栓塞术对多种恶性肿瘤有效,但关于治疗胰腺腺癌的数据甚少。我们报告了一例转移性胰腺腺癌诊断后一年完全的影像学缓解。基于吉西他滨/顺铂的化疗栓塞可能对胰腺腺癌肝转移为主的患者有益。鉴于该患者组采用标准疗法的典型生存时间为 6 个月或更短,需要进一步研究。

相似文献

1
One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.吉西他滨和顺铂化疗栓塞治疗后分化不良转移性胰腺癌 1 年生存。
Oncol Rep. 2010 Sep;24(3):767-9. doi: 10.3892/or_00000919.
2
Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma.使用SPECT/CT联合系统对融合图像上肝内和胰腺灌注进行比较,并评估晚期胰腺癌中持续动脉灌注与全身化疗联合应用的疗效。
Cardiovasc Intervent Radiol. 2007 Sep-Oct;30(5):912-21. doi: 10.1007/s00270-007-9134-2. Epub 2007 Aug 21.
3
Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.新辅助FOLFIRINOX治疗及R0切除的转移性胰腺癌
World J Gastroenterol. 2015 May 28;21(20):6384-90. doi: 10.3748/wjg.v21.i20.6384.
4
Oily chemoembolization of pancreatic head adenocarcinoma.胰头腺癌的油性化疗栓塞术
Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):424-6. doi: 10.1007/s00270-001-0040-8. Epub 2001 Nov 8.
5
Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01).局部进展期可切除胰腺癌新辅助治疗的 II 期研究:序贯 S-1 为基础的同期放化疗后联合吉西他滨系统化疗(HOPS-BR01)
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):606-617. doi: 10.1016/j.ijrobp.2019.07.004. Epub 2019 Jul 12.
6
Hepatic arterial infusion chemotherapy reduced hepatic metastases from pancreatic cancer after pancreatectomy.肝动脉灌注化疗可减少胰腺癌胰十二指肠切除术后的肝转移。
Hepatogastroenterology. 2014 Jul-Aug;61(133):1415-20.
7
How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple liver and bone metastases.胰腺癌的生长速度有多快?有一例胰腺癌在一次检查结果为阴性后的5个月内就发展到了晚期,并伴有多处肝转移和骨转移。
Pancreas. 2011 Mar;40(2):318-9. doi: 10.1097/MPA.0b013e3181fe4031.
8
Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.对于局部晚期不可切除胰腺癌,在新辅助放化疗(吉西他滨和S-1)及同步放疗后行胰腺切除术并进行主要动脉切除。
Surgery. 2015 Jul;158(1):191-200. doi: 10.1016/j.surg.2015.02.016. Epub 2015 Apr 18.
9
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.术前全剂量吉西他滨、同期三维适形放疗、手术及术后肝灌注化疗联合治疗T3期胰腺癌的可行性和疗效
Ann Surg. 2009 Jul;250(1):88-95. doi: 10.1097/SLA.0b013e3181ad65cc.
10
Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.辅助性吉西他滨治疗的完整性、复发模式及后续治疗对切除的胰腺导管腺癌患者预后的影响——CONKO-001、CONKO-005和CONKO-006试验的汇总分析
Eur J Cancer. 2021 Jun;150:250-259. doi: 10.1016/j.ejca.2021.03.036. Epub 2021 Apr 30.

引用本文的文献

1
A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review.一例组织发生不明的类似肝样癌的胰腺腺癌:病例报告及文献复习
Oncol Lett. 2023 Aug 28;26(4):442. doi: 10.3892/ol.2023.14029. eCollection 2023 Oct.
2
Safety and efficacy of locoregional therapy for metastatic pancreatic ductal adenocarcinoma to the liver: a single-center experience.局部区域治疗转移性肝胰管腺癌的安全性和疗效:单中心经验
J Gastrointest Oncol. 2019 Aug;10(4):688-694. doi: 10.21037/jgo.2019.03.13.
3
Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.
经导管动脉化疗栓塞术治疗胰腺癌肝转移的疗效
Oncotarget. 2017 Jun 13;8(24):39746-39755. doi: 10.18632/oncotarget.14642.
4
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.载药微球肝动脉化疗栓塞治疗转移性胰腺癌肝转移:多中心登记研究。
J Oncol. 2012;2012:168303. doi: 10.1155/2012/168303. Epub 2012 Feb 15.
5
Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families.细胞周期蛋白D1起抑制作用,而c-Myc通过调节NF-κB和Bcl-2家族的多个成员来增强顺铂对小鼠胰腺癌细胞的细胞毒性。
J Carcinog. 2011;10:24. doi: 10.4103/1477-3163.90437. Epub 2011 Nov 30.